Dutasteride and Enclomiphene Interaction
Dutasteride and Enclomiphene have a potentially harmful interaction with 64% confidence. Both Dutasteride and Enclomiphene carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. These compounds primarily affect different organ systems.
Compound Profiles
Dutasteride
Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH
Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, while Type I is found primarily in the skin, sebaceous glands, and liver.
View full profileEnclomiphene
Selective Estrogen Receptor Modulator | Testosterone & Fertility Support
Enclomiphene competitively antagonizes estrogen receptors in the hypothalamus and anterior pituitary, blocking the negative feedback of estradiol on GnRH release. This disinhibition increases pulsatile GnRH secretion, which in turn stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Dutasteride with Enclomiphene?
Combining Dutasteride with Enclomiphene is not recommended. Both Dutasteride and Enclomiphene carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Is Dutasteride and Enclomiphene safe together?
This combination carries significant risk. Both Dutasteride and Enclomiphene carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.
What are the interactions between Dutasteride and Enclomiphene?
Both Dutasteride and Enclomiphene carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.
How should I time Dutasteride and Enclomiphene?
Dutasteride has a half-life of ~5 weeks (extremely long; active metabolite accumulation over months) and Enclomiphene has a half-life of ~10 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.